A new cervical cancer treatment is showing promise in boosting survival rates and reducing recurrence What this breakthrough means for patients.

A mother of three was blindsided by a cervical cancer diagnosis just days before her 30th birthday — despite experiencing ...

In the early stages, cervical cancer may not show obvious symptoms. However, it is crucial to be aware of possible signs to ...

Chemoradiation with platinum-based chemo is standard for locally advanced cervical cancer, but adverse events drive ...

Pap smears save many lives, but many women avoid the uncomfortable and intrusive procedure. New self-test kits could change ...

Regeneron UK Limited has announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo (cemiplimab) for use on ...

Cervical cancer is one of the most preventable cancers, yet it remains a significant health threat. Here’s why prevention is ...

A pregnant twenty two year old Angella Kagoya, a survivor of cervical cancer in Mayuge District, Uganda, hangs clothes on a ...

The European Medicines Agency has recommended three new medicines to treat breast and cervical cancer and ...

Pembrolizumab has robust, durable clinical benefit in patients with heavily pretreated CCGC and was tolerated in the overall population,” researchers wrote.

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...